BioCentury | Dec 2, 2016
Company News

Portage spins out EyGen

...Portage spun out EyGen Ltd. (Toronto, Ontario), which will focus on developing preclinical opthalmologic and inflammatory compounds...
...permeable peptide fusion protein that is in development to treat dry eye disease. Portage said EyGen...
...meeting in mid-2017. Portage Biotech Inc. (OTCBB:PTGEF; CNSX:PBT.U), Toronto, Ontario Business: Opthalmic, Inflammatory Nora Weintraub PPL-003 Portage Biotech Inc. EyGen Ltd....
Items per page:
1 - 1 of 1
BioCentury | Dec 2, 2016
Company News

Portage spins out EyGen

...Portage spun out EyGen Ltd. (Toronto, Ontario), which will focus on developing preclinical opthalmologic and inflammatory compounds...
...permeable peptide fusion protein that is in development to treat dry eye disease. Portage said EyGen...
...meeting in mid-2017. Portage Biotech Inc. (OTCBB:PTGEF; CNSX:PBT.U), Toronto, Ontario Business: Opthalmic, Inflammatory Nora Weintraub PPL-003 Portage Biotech Inc. EyGen Ltd....
Items per page:
1 - 1 of 1